Most Popular
-
1
N. Korea fires multiple short-range ballistic missiles toward East Sea
-
2
Samsung’s yearly dilemma looms: Exynos vs. Snapdragon
-
3
Yoon to visit Prague next week to forge 'nuclear energy alliance'
-
4
Is NewJeans leaving Hybe?
-
5
1 in 4 Korean workers extend Chuseok holiday with paid leave: survey
-
6
Life sentence finalized for killer in Sillim rampage
-
7
Hit with lifetime ban, football player Son Jun-ho claims innocence, says China forced him to admit fake charges
-
8
What comes after love? Ex-lovers cross paths in new Coupang Play series
-
9
Hyundai Motor, GM join hands to shake up EV landscape
-
10
Why is NK back to firing missiles after monthslong hiatus?
-
Zymo Research Makes Strategic Investment in Star Array to Develop an Automated Nucleic Acid Extraction/Superfast PCR Platform for the POCT Market
IRVINE, Calif., April 27, 2022 /PRNewswire/ -- Zymo Research and Star Array today announced Zymo Research's strategic investment to acquire an interest in Star Array, a privately owned, biomedical technology company based in Singapore. The investment allows Zymo Research and Star Array to combine Zymo Research's nucleic acid purification and assay technologies with Star Array's engineering and automation expertise to expand into emerging For Research Use Only (FRUO) and diagnostic markets incl
April 27, 2022
-
Blockchain Association Singapore brings BNY Mellon on board as a strategic collaborator to drive adoption and innovation in blockchain and decentralised finance
SINGAPORE, April 27, 2022 /PRNewswire/ -- Blockchain Association Singapore (BAS) today announced global financial institution BNY Mellon has come on board as a strategic collaborator. With the signing of a Memorandum of Understanding (MOU), BAS and BNY Mellon will cooperate to advance the blockchain ecosystem, driving global cooperation regarding institutional digital assets and decentralised finance (DeFi). BAS and BNY Mellon will seek collaboration opportunities and share expertise with the wi
April 27, 2022
-
CNN's 'Mission: Ahead' meets the pioneers pushing the boundaries of technology to save lives
A week of special coverage airs April 25-29, with a 30-minute program airing May 1 HONG KONG, April 27, 2022 /PRNewswire/ -- CNN's 'Mission: Ahead' is a brand-new cross-platform series which explores the world's biggest challenges - from climate change to disease - and profiles the fearless and impassioned leaders who are tackling them with innovative projects that our future depends on. CNN’s ‘Mission: Ahead’ meets the pioneers pushing the boundaries of technology to save lives In
April 27, 2022
-
Visa unveils five startups in 2022 cohort of its accelerator program
SINGAPORE, April 27, 2022 /PRNewswire/ -- Visa, the world leader in digital payments, has selected five startups to join the 2022 cohort of its Visa Accelerator Program in Asia Pacific: Cymonz, Moneytree, Perfios, TallyKhata and TripleA. Over the next six months, the startups will work closely with Visa on creating defined commercial opportunities they can bring to Visa's extensive network of bank, merchant, government and venture partners. "Through the Accelerator Program, Visa support
April 27, 2022
-
PNY XLR8 SSD Cover Wins Red Dot Award: Product Design 2022 with Integrated Heatsink designed to fit PS5(TM)
HSINCHU, April 27, 2022 /PRNewswire/ -- PNY is honored to announce their selection as a winner of a Red Dot Award: Product Design for the XLR8 SSD Cover with Integrated Heatsink, designed to fit PS5™. This product was engineered to replace the standard SSD cover and offers easy installation when upgrading the expanded SSD storage**. PNY XLR8 SSD Cover with Integrated Heatsink designed to fit PS5™ In 2022, designers and manufacturers from 60 countries entered products to be c
April 27, 2022
-
Antengene Announces Submission to the Human Research Ethics Committee in Australia for a Phase I Trial of ATG-018
Developed in-house by internal R&D Team at Antengene, ATG-018 is an orally-available, small molecule ATR inhibitor that targets DNA Damage Response (DDR) pathways. The Phase I study will evaluate the safety, pharmacology and preliminary efficacy of ATG-018 in patients with advanced solid tumors and hematologic malignancies. ATG-018 has the potential as the first orally-available, small molecule ATR inhibitor entering clinical development in Australia. SHANGHAI and HONG KONG,
April 27, 2022
-
London's iconic West End presents untapped opportunities for Korean investors and brands in the retail sector to thrive and grow
Figures indicate that London is the most attractive city for international retail trade companies to expand to US and European brands are leading expansion into London, with data demonstrating significant untapped potential for the Asia region in London Turnover in the West End is expected to reach £11.4 billion in 2025, indicating strong returns for Asian retailers looking to scale overseas SEOUL, South Korea, April 27, 2022 /PRNewswire/ -- New investment data from Lo
April 27, 2022
-
Midea Announces The Acquisition of TTIUM Motor, Enter the Green Two-wheel Vehicle Market Officially
WUHAN, China, April 27, 2022 /PRNewswire/ -- Midea announced the acquisition of Wuhan TTIUM Motor Technology CO., LTD (TTIUM). With this strategic move, it marks that Midea has officially entered the "two-wheel vehicle" market and further refreshed its product portfolio. The signing of the contract between Midea Industrial Technology and TTIUM Motor Technology CO., LTD (TTIUM) Looking forward, Midea and TTIUM Motor will hope to achieve a "win-win"
April 27, 2022
-
GROUPM ANNOUNCES NEXT STEPS IN ITS TRANSFORMATION WITH ENHANCED AGENCY OFFERINGS AND UNIFIED PERFORMANCE ORGANIZATION
Essence and MediaCom to merge, forming EssenceMediacom GroupM Nexus to launch globally as a best-in-class performance organization Mindshare to complete the integration with global performance agency Neo LONDON and NEW YORK and SAN FRANCISCO, April 27, 2022 /PRNewswire/ -- GroupM, WPP's media investment group, today announced the latest steps in its transformation to accelerate innovation for clients and further simplify its operations. The moves, which build on the April 2021 launch of
April 27, 2022
-
FDA Approves Direct Biologics to Proceed with a Landmark Phase 3 Acute Respiratory Distress Syndrome (ARDS) Trial
AUSTIN, Texas, April 27, 2022 /PRNewswire/ -- Direct Biologics, a regenerative biotechnology company with a groundbreaking extracellular vesicle (EV) platform technology, announced today that the FDA has approved the company to proceed with its Phase 3 clinical trial using its investigational EV drug, ExoFlo, to treat Acute Respiratory Distress Syndrome (ARDS) due to Covid-19. Direct Biologics is the first and only EV company to receive FDA Phase 3 approval for an Investigational New Drug (IND)
April 27, 2022
-
Infosys Collaborates with Nu Skin to Drive Social Commerce-led Transformation in the Beauty and Wellness Sector
BENGALURU, India and NEW YORK, April 26, 2022 /PRNewswire/ -- Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in next-generation digital services and consulting, today announced its collaboration with Nu Skin Enterprises, Inc. (NYSE: NUS), a global leader in beauty and wellness. Nu Skin will take advantage of the Infosys Equinox human-centric digital commerce platform to deliver engaging and innovative experiences for consumers and affiliates. The platform aims to help Nu Sk
April 26, 2022
-
FP Markets launches the FP Markets Partners Hub. The premium choice for IBs & Affiliate Marketing experts
The FP Markets Partners Hub is a rich source of information for partners containing marketing material and in-depth informative articles and tips for IBs and Affiliates to learn how to maximise their earning potential SYDNEY, April 26, 2022 /PRNewswire/ -- FP Markets has launched its informative Partners Hub for IBs & Affiliate Marketing experts. The new and exclusive FP Markets Partners Hub is an additional benefit to joining FP Markets as a Partner and is an informative
April 26, 2022
-
Launched: Infosys Cobalt Financial Services Cloud, an Industry Cloud Platform to help Firms Unleash the Power of Cloud-Driven Transformation
With out-of-the-box industry services, assets, and frameworks, the new financial services cloud platform sets the stage for accelerating business value in the cloud NEW YORK, April 26, 2022 /PRNewswire/ -- Infosys (NYSE: INFY), a global leader in next-generation digital services and consulting, today announced the launch of Infosys Cobalt Financial Services Cloud, an industry cloud platform for enterprises to accelerate business value and innovation in the cloud across the financial ser
April 26, 2022
-
Indonesian Technology Company, WIR Group To Introduce Metaverse Prototype To Embrace The Web 3.0 Era
JAKARTA, Indonesia, April 26, 2022 /PRNewswire/ -- WIR Group, an Indonesia-based metaverse technology company, will reveal its Metaverse prototype within the 4th quarter of 2022 as part of its vision to create a liveable world of metaverse for everyone entering the Web 3.0 era'. As a company, WIR Group is committed to enriching life experiences for individuals, companies, and societies through digital reality solutions encompassing Augmented Reality (AR), Virtual Reality (VR), and Artificia
April 26, 2022
-
Seegene unveils world's first commercialized '3 Ct' PCR assay
Provides Ct value of three targets in one channel; '3 Ct' PCR assay to launch in H1 "Dream MDx technology" developed based on Seegene's 20-year expertise; combines 19 different patented technologies, including DPO™, TOCE™, MuDT™ '3 Ct' to lay foundation for automated syndromic testing and make MDx more accessible SEOUL, South Korea, April 26, 2022 /PRNewswire/ -- Seegene Inc. (KQ096530), South Korea's leading molecular diagnostics (MDx) company, today announced the developm
April 26, 2022
-
PharmAbcine Announces Positive Results for Its Novel TIE2-Activating Antibody in GLP Toxicology Study
DAEJEON, South Korea, April 26, 2022 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of next-generation antibody therapeutics, announced today the positive results from the GLP toxicology study of PMC-403, the Company's novel TIE2-activating antibody. PMC-403 can stabilize and repair damaged and pathologically leaky blood vessels, and it is being developed to treat AMD (Age-related Macular Degeneration), one of the m
April 26, 2022
-
Huawei: Innovating Nonstop for a Greener Intelligent World
SHENZHEN, China, April 26, 2022 /PRNewswire/ -- Huawei kicked off its 19th annual Global Analyst Summit today in Shenzhen. A hybrid event, the summit gathers industry analysts, financial analysts, key opinion leaders, and media representatives from around the world to learn more about future industry trends and Huawei's development strategy. At the event, Ken Hu, Huawei's Rotating Chairman, gave a keynote on Huawei's approach to innovation and building a greener intelligent world. "We wil
April 26, 2022
-
PharmAbcine Strengthens Scientific Advisory Board with a World-Renowned Expert in Ophthalmology
DAEJEON, South Korea, April 26, 2022 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of next-generation antibody therapeutics, announced today the appointment of Quan Dong Nguyen, MD, MSc, FAAO, FARVO, FASRS to its Scientific Advisory Board. "We are very honored to have Professor Nguyen as a new member to our Scientific Advisory Board," commented Dr. Jin-San Yoo, CEO of PharmAbcine. "Professo
April 26, 2022
-
Geek+'s first large-scale four-way shuttle deployment powers major Chinese green energy project
Groundbreaking Sky-Storage & Ground-Pick solution has been in successful operation for over six months in TICA Systems' manufacturing facilities. This is the first large-scale implementation of new Geek+ solution providing ultra-high pallet storage density without sacrificing picking speed and efficiency. NANJING, China, April 26, 2022 /PRNewswire/ -- Geek+, the global leader in AMR technology, has put its latest technology to work modernizing operations at TICA Systems, a major Chin
April 26, 2022
-
Holmusk Announces Publication of Seminal Paper on Real-World Evidence (RWE) Platform NeuroBlu
NEW YORK, April 26, 2022 /PRNewswire/ -- Holmusk, a leading global data science and health technology company building the world's largest real-world evidence (RWE) platform for behavioral health, is pleased to share with the scientific community in-depth details about its platform via the publication of a paper in BMJ Open. The publication centers on the dataset available within NeuroBlu, Holmusk's flagship RWE platform. NeuroBlu is a trusted research environment (TRE) that enables a wide range
April 26, 2022